Biomea Fusion (BMEA) IPO Opens 15% Higher

April 16, 2021 11:53 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Today's IPO for Biomea Fusion, Inc. (NASDAQ: BMEA) opened for trading at $20 after pricing 9,000,000 shares of its common stock at a public offering price of $17.00 per share.

J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co. are acting as joint book-running managers for the offering.

Biomea Fusion is a preclinical-stage biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

IPOs

Related Entities

JPMorgan, Jefferies & Co, IPO